Literature DB >> 9789259

Increased apoptosis coincides with onset of involution in infantile hemangioma.

M J Razon1, B M Kräling, J B Mulliken, J Bischoff.   

Abstract

OBJECTIVE: Hemangioma is an endothelial cell tumor that grows rapidly during infancy and regresses slowly during childhood. However, little is known about the natural history of this common tumor. To gain insight into the cellular mechanisms that underlie the switch from uncontrolled growth to involution of endothelium, we investigated the extent of cellular apoptosis versus proliferation in hemangioma specimens that spanned the natural life cycle of the tumor.
METHODS: We analyzed apoptosis and cellular proliferation in frozen sections from 16 hemangioma specimens using the TUNEL assay to detect apoptotic cells and the Ki67 antigen to detect dividing cells.
RESULTS: Apoptosis was low in proliferative phase hemangiomas but increased fivefold in involutive phase specimens obtained from children one to four years of age. Immunofluorescence double-labeling experiments showed that at least one third of the apoptotic cells were endothelial. As expected, cellular proliferation was high in specimens up to 2 years of age but decreased significantly thereafter. Apoptosis was consistently low in nine normal skin tissues (newborn to 4 years of age) obtained from discarded pathology specimens.
CONCLUSIONS: These results suggest that increased apoptosis during the second year of life can offset cellular proliferation and may be involved in initiating regression of hemangioma.

Entities:  

Mesh:

Year:  1998        PMID: 9789259

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  25 in total

Review 1.  Pathogenesis of hemangioma.

Authors:  D A Marchuk
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

3.  M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.

Authors:  Keith Q Wu; Christopher S Muratore; Eui-Young So; Changqi Sun; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

4.  A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis.

Authors:  Burcu Belen; Aynur Oguz; Arzu Okur; Buket Dalgic
Journal:  BMJ Case Rep       Date:  2014-05-19

5.  Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis.

Authors:  Matthew R Ritter; Michael I Dorrell; Joseph Edmonds; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.

Authors:  M Snir; U Reich; R Siegel; A Zvulunov; R Friling; N Goldenberg-Cohen; Y Ron; D Ben-Amitay
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

7.  Differential expression of ABH histo-blood group antigens and LAMPs in infantile hemangioma.

Authors:  V Sarafian; D Dikov; M Karaivanov; V Belovejdov; P Stefanova
Journal:  J Mol Histol       Date:  2006-03-29       Impact factor: 2.611

8.  Clonality and altered behavior of endothelial cells from hemangiomas.

Authors:  E Boye; Y Yu; G Paranya; J B Mulliken; B R Olsen; J Bischoff
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

9.  Beta-blockers as therapy for infantile hemangiomas.

Authors:  Harrison P Nguyen; Brent B Pickrell; Teresa S Wright
Journal:  Semin Plast Surg       Date:  2014-05       Impact factor: 2.314

10.  PDGFR-β (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo.

Authors:  Si-Ming Yuan; Yao Guo; Xiao-Jun Zhou; Wei-Min Shen; Hai-Ni Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.